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Abstract
Background: Previous studies have linked cardiac dysfunction to loss of metabolites in the creatine kinase system.
Chemical exchange saturation transfer (CEST) is a promising metabolic cardiovascular magnetic resonance (CMR)
imaging technique and has been applied in the heart for creatine mapping. However, current limitations include:
(a) long scan time, (b) residual cardiac and respiratory motion, and (c) B0 field variations induced by respiratory motion.
An improved CEST CMR technique was developed to address these problems.
Methods: Animals with chronic myocardial infarction (N = 15) were scanned using the proposed CEST CMR technique
and a late gadolinium enhancement (LGE) sequence as reference. The major improvements of the CEST CMR
technique are: (a) Images were acquired by single-shot FLASH, significantly increasing the scan efficiency. (b) All images
were registered to reduce the residual motion. (c) The acquired Z-spectrum was analyzed using 3-pool-model
Lorentzian-line fitting to generate CEST signal, reducing the impact of B0 field shifting due to respiratory motion.
Feasibility of the technique was tested in a porcine model with chronic myocardial infarction. CEST signal was
measured in the scar, border zone and remote myocardium. Initial studies were performed in one patient.
Results: In all animals, healthy remote myocardial CEST signal was elevated (0.16 ± 0.02) compared to infarct CEST
signal (0.09 ± 0.02, P < 0.001) and the border zone (0.12 ± 0.02, P < 0.001). For both animal and patient studies,
the hypointense regions in the CEST contrast maps closely match the bright areas in the LGE images.
Conclusions: The proposed CEST CMR technique was developed to address long scan times, respiratory and
cardiac motion, and B0 field variations. Lower CEST signal in bright region of the LGE image is consistent with the fact
that myocardial infarction has reduced metabolic activity.
Keywords: MRI, Cardiac CEST, Creatine, Metabolic imaging, CEST CMR
Background
Adenosine triphosphate (ATP) is an essential energy
source that governs myocardial contraction [1]. The cre-
atine kinase (CK) system plays a vital role in the synthe-
sis of myocardial ATP. ATP is generated from the
conversion of phosphocreatine (PCr) and adenosine
diphosphate (ADP) to creatine (Cr) catalyzed by CK.
Previous studies have linked cardiac dysfunction to the
loss of metabolites in the CK system [2–4]. The meas-
urement of Cr or PCr can serve as a biomarker to inves-
tigate the metabolic change in the myocardium [5–9].
Chemical exchange saturation transfer (CEST) is an
emerging MRI technique for metabolic imaging [10]. By
saturating the solute protons, water signal will also drop
because of the constant exchange between solute pro-
tons and water protons [11]. It has been shown that
CEST can be used to map Cr distribution because of
chemical transfer between its amine protons (−NH2) and
water protons. CEST can detect Cr separately from other
CK metabolites because Cr protons alone have an
intermediate transfer rate with water protons [12–14].
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Compared to MR spectroscopy techniques, CEST yields
better spatial resolution and higher sensitivity because of
indirect detection via water protons [14, 15].
CEST has been applied in the heart for in vivo en-
dogenous Cr imaging in animal studies [16–19]. Haris et
al. was the first to show the feasibility of high-spatial-
resolution mapping of Cr using CEST cardiovascular
magnetic resonance (CMR). However, the method poses
some technical challenges which could potentially hinder
the clinical translation of the CEST CMR technique: (a)
long scan time (~50 min per slice), (b) residual cardiac
and respiratory motion, and (c) B0 field variations mostly
induced by respiratory motion.
In this study, we developed a clinically translatable
CEST CMR technique with significantly reduced scan
time (~5 min), improved motion registration and CEST
signal analysis to address the aforementioned challenges.
The proposed technique was then validated in chronic
myocardial infarction porcine model using late gadolin-
ium enhancement (LGE) as a reference. This animal
model was chosen because it has been clearly shown
that scar regions have reduced metabolic activity level
compared to remote myocardium [20]. A repeatability
study was performed in healthy subjects, and an initial
patient study is presented.
Methods
Animal study
All animal-related procedures were approved by the
Institutional Animal Care and Use Committee (IACUC)
at Cedars-Sinai Medical Center. Myocardial infarction
was induced in 15 Yucatan minipigs following the pro-
cedure described in a previous study [21]. Specifically,
animals were sedated by intramuscular ketamine 20 mg/
kg, acepromazine 0.25 mg/kg and atropine 0.05 mg/kg,
followed by 10 mL intravenous thiopental. Endotracheal
intubation was then performed, and anesthesia main-
tained by ventilation with 1% to 2% isoflurane. Catheters
were inserted through the left carotid artery. Coronary
X-ray angiography was performed to visualize the cor-
onary arteries and identify the site for occlusion. An
anteroseptal myocardial infarction was induced by in-
flation of an angioplasty balloon in the mid-left anter-
ior descending artery to cause coronary occlusion for
2.5 h. Finally, the animals were taken to the post-op
recovery room. All imaging was performed eight
weeks after the infarction.
Animal study (N = 15) was performed on a 3 Tesla
clinical scanner (Magnetom Verio; Siemens Healthi-
neers, Erlangen, Germany) using a 12-channel phase
array coil for data acquisition. Throughout the im-
aging procedures, anesthesia was maintained with iso-
flurane (1–3.5%).
The imaging protocol included balanced steady state
free precession (bSSFP) cine, CEST CMR and LGE. bSSFP
cine was performed to localize the quiescent period of the
cardiac cycle (1.4 × 1.4 × 6 mm3; electrocardiogram-gated;
35 cardiac phases; TR/TE = 3.2/1.6 ms; flip angle 50°).
LGE imaging was completed 15 min after the contrast
agent injection (0.1 mmol/kg, gadobutrol, Gadovist, Bayer
Healthcare, Berline, German) using phase sensitive inver-
sion recovery FLASH (1.3 × 1.3 × 6 mm3; TR/TE/TI =
362/1.5/335 ms; flip angle 20°). All imaging was performed
in the short axis plane at three mid-ventricular slice loca-
tions of the left ventricle. Breath hold was controlled by a
ventilator in cine imaging and LGE imaging.
CEST CMR scans were performed before the contrast
injection using FLASH readout (resolution 2.1 × 2.1 mm2;
slice thickness 6–8 mm; TR/TE = 4000/1.5 ms; flip angle
12°). Figure 1 shows the pulse sequence diagram of the
proposed CEST CMR technique. Electrocardiogram trig-
gering and navigator gating were used to reduce the effects
of cardiac and respiratory motion. Each image was ac-
quired by single-shot FLASH (~200 ms readout block
placed in quiescent period). Thirty-three images were col-
lected at different saturation frequency offsets ranging
from −4.8 ppm to 4.8 ppm with a step size of 0.3 ppm. The
CEST preparation module consists of five Gaussian-shaped
pulses with 2700° flip angle and 30 ms duration at a duty
cycle of 50% (the equivalent B1 power is 3.76 uT). The
spoiler gradient was altered in different directions to crush
the residual transverse magnetization. An additional image
was acquired without CEST saturation for normalization
reference. The scan time for each slice was approximately
5 min with 40% navigator efficiency.
CEST CMR technique was optimized in the following
aspects: (a) Images were acquired by single-shot FLASH
instead of segmented acquisition, significantly increasing
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Fig. 1 (a) Pulse sequence diamgram of the optimized CEST CMR
techniue. (b) CEST preparation module used in the proposed CEST
CMR sequence
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the scan efficiency. (b) All images were registered to
reduce the residual left ventricle wall motion (up to
4 mm myocardial displacement) using Medical Imaging
Registration Toolbox (MIRT) [22]. (c) The acquired Z-
spectrum was fitted to the Lorentzian-shaped 3-pool-
model to increase the reliability of the generated CEST
contrast map by reducing the impact of signal fluctuation
from B0 field shifting introduced by respiratory motion.
Healthy subject study
CEST CMR in healthy subjects (n = 14) was performed
on a 3 T clinical scanner (Magnetom Verio; Siemens
Healthineers) using a 32-channel phase array coil for
data acquisition. For the healthy subject and patient im-
aging studies, the protocol was approved by Institutional
Review Board at Cedars-Sinai Medical Center and writ-
ten informed consent was obtained from each subject
before the exam. For each healthy subject, repeatability
of the proposed CEST CMR method was evaluated in
two mid-ventricular slices by repeating the scan twice in
the same imaging position.
The parameters of CEST CMR sequence used in
healthy subject study were similar compared to the ani-
mal study. Each image was acquired by single-shot
FLASH (Field-of-view: 350 × 280 mm2; spatial reso-
lution: 2.7 × 2.2 × 8.0 mm3; TR/TE = 4000/1.45 ms;
matrix size: 160 × 104; iPAT: 2; flip angle: 12°; acquisition
window: 163 ms). 3 Gaussian-shaped pulses with flip
angle of 2700° and pulse duration of 80 ms were used in
the CEST preparation module. The interpulse delay was
80 ms. Equivalent RF irradiation power is 1.90 uT. CEST
saturation frequency offsets range from −3.6 ppm to
3.6 ppm with a step size 0.3 ppm. An additional image
was acquired without CEST saturation for normalization
reference. The scan time for each slice was approxi-
mately 5 min with 30% navigator efficiency.
Image analysis
Post processing was performed with custom-written pro-
grams in Matlab (The Mathworks, Natick, Massachusetts,
USA). For each pixel, the Z-spectrum was generated as
the signal intensity of each image acquired at different sat-
uration frequency offsets normalized by the reference
image. By using 3-pool-model Lorentzian-line fitting, the
acquired Z-spectrum was separated into CEST, direct
water saturation (DWS), and conventional magnetization
transfer (MT), three major effects in saturation exper-
iments with aqueous solutions [16, 23]. The center of
the DWS curve is the central water frequency, which
represents B0 field information. The distance between
the center of the CEST curve and DWS curve is con-
stantly +1.8 ppm, which is the resonant frequency of
amine protons. CEST signal is defined as the ampli-
tude of the fitted CEST curve.
CEST maps were generated using pixel-by-pixel
Z-spectrum fitting in the myocardium. In the animal
study, regions of interest (ROIs) were placed in the scar
region, remote myocardium and border zone adjacent to
the infarcted myocardium using LGE as reference. The
average CEST signal was determined in scar, border zone
and healthy remote myocardium, for each subject.
Comparisons were performed using repeated measures
one-way ANOVA analysis followed by Tukey’s multiple
comparisons test in GraphPad Prism 6 (Graph-Pad
Software, La Jolla, California, USA). A two-tailed value
of p < 0.05 was considered to be statistically significant.
In the healthy subject studies, the average CEST sig-
nal was calculated in the entire myocardium (“global”)
and in the septum. The repeatability was evaluated by
performing Bland-Altman plot in GraphPad Prism 6
(GraphPad Software).
Patient study
One patient who was referred for LGE CMR exam for
evaluation of chronic myocardial infarction was studied
using the proposed CEST CMR sequence with the same
settings/parameters as the volunteer studies. LGE im-
aging was completed 15 min after the contrast agent in-
jection (0.1 mmol/kg, gadobutrol, Gadovist, Bayer Inc.)
using phase sensitive inversion recovery FLASH (1.4 ×
1.4 × 8 mm3; TR/TE/TI = 330/1.6/300 ms; flip angle 20°).
Results
Animal study
In total, the CEST CMR scans were performed in 15 ani-
mals. The heart rates of the animals were in the range of
100–120 beats/min during the CMR scan.
To separate the CEST signal from MT and DWS
effects, we used 3-pool-model fitting to analyze the
Z-spectrum (Fig. 2). The peak of the CEST curve is de-
fined as CEST signal, which is used in the following quan-
titative analysis. Comparing the Z-spectrum analysis
curves in the scar with those in the healthy myocardium,
it is clear that CEST signal is lower in the scar region.
Figure 3 shows typical CEST contrast maps and corre-
sponding LGE images in three slice locations. The in-
farcted regions have lower CEST signal than healthy
remote myocardium. Spatially, the hypointense regions
in the CEST contrast maps closely match the bright
areas in LGE images.
In all animals, infarct CEST signal (0.09 ± 0.02) is sig-
nificantly reduced compared to the CEST signal found in
the healthy remote myocardium (0.16 ± 0.02), p < 0.001, as
shown in Fig. 4. The CEST signal in the border zone
(0.12 ± 0.02) was also reduced compared to the re-
mote myocardium, p < 0.001, while it was elevated
compared to the infarcted tissue, p < 0.001.
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Healthy subject study
Fourteen healthy subjects (10 male, 39 ± 13 years, BMI
24 ± 4) were included in the studies. The average scan
time of each slice was 4.8 ± 2.8 min.
The Bland-Altman plots of global CEST signal and
septal CEST signal were shown in Fig. 5a and b, respect-
ively. The 95% limits of agreement of the global CEST
signal were −0.07 to 0.06, while the 95% limits of agree-
ment of the septal CEST signal were −0.06 to 0.05.
Patient study
The CEST map and the corresponding LGE image of
the patient study were shown in Fig. 6. The hypointense
region in the CEST maps is consistent with the scar
region shown on the LGE image.
Discussion
In this work, we developed a CEST CMR technique with
significantly reduced scan time (~5 min), improved mo-
tion registration and CEST signal analysis to show the
feasibility of the proposed technique in detecting Cr dis-
tribution in the myocardium in a clinically feasible scan
time. The animal study showed decreased CEST signal
in infarcted region compared to remote myocardium,
which is consistent with previous finding [16]. The re-
peatability healthy subject studies and the preliminary
patient result also suggest initial feasibility of the pro-
posed CEST CMR technique.
As CK metabolites are essential in providing energy
for myocardial contraction, cardiac metabolic impair-
ment is now considered as a cause, rather than a result
of cardiac diseases [24]. Detection of CK metabolites
ba
Fig. 2 Z-spectrum of (a) scar region and (b) healthy myocardium. By using the 3-pool-model fitting, Z-spectrum (black) was separated into CEST
curve (pink), MT curve (blue) and DWS curve (green). The center of DWS curve represents the resonant water frequency (B0 field). The peak of CEST
curve was defined as the CEST signal. It is clear that the healthy myocardium has higher CEST signal than scar, which suggests more Cr distribution in
the healthy myocardium
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Fig. 3 (a) CEST maps and (b) corresponding LGE images of one representative subject in three slice locations. The hypointense regions (arrows)
in the CEST maps match the LGE positive regions (arrows)
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such as creatine can potentially help the clinical diag-
nosis and treatment of cardiovascular diseases. It can
be used to further understand the underlying mecha-
nisms of metabolic change processes in these diseases
as well as to evaluate therapy efficiency and guide
therapy optimization.
In this study, we compared the CEST signal in the scar,
border zone and remote myocardium. As expected, the
CEST signal in the scar was significantly reduced com-
pared to the CEST signal in the remote myocardium.
This is consistent with the previous findings that the in-
farcted tissue has reduced metabolic activity [20]. More
interestingly, the CEST signal in the border zone was
also significantly reduced compared to the remote myo-
cardium. This potentially suggests that the border zone
might also have reduced myocardial metabolic activity.
However, a more comprehensive study needs to be per-
formed to further demonstrate this point.
Cardiac MR Spectroscopy (CMRS) is also capable of
detecting the activity of CK metabolites in the myocardium.
PCr and ATP can be detected as two peaks in 31P
spectrum. The ratio of PCr over ATP can serve as an indi-
cator of myocardial energy metabolism [5, 25]. In 1H
spectrum, Cr and PCr have the same chemical shift and
only their combined total amount can be measured [6, 26].
However, these techniques have not gained common
application over the years because of limitations such
as low spatial resolution, lengthy scan time, and com-
plicated acquisition protocol. 31P CMRS also requires
additional hardware, which limits its availability. All
of these issues hinder the clinical translation of
CMRS approaches. However, they can be potentially
addressed by CEST CMR techniques. In this study,
we have shown the feasibility of CEST CMR technique
with typical CMR spatial resolution and clinically accept-
able scan time. CEST CMR is also more sensitive com-
pared to CMRS techniques because the signal is indirectly
detected from the water pool. Without any special
requirement for hardware or technician training, this
technique can be easily translated into clinical studies.
The CEST CMR sequence we proposed in this study is
significantly faster than the previous technique [16]. One
of the major reasons is that we used single-shot FLASH
readout instead of segmented readout. In addition to its
contribution to speed acceleration, single-shot readout
also minimizes the respiratory motion within the acqui-
sition of each CEST-weighted image at different satur-
ation frequency offsets. This reduces the motion
artifacts and B0 field changes within the acquisition
of each single image. It should be noted, though,
when the subject has a relatively high heart rate and
short quiescent period, the image acquired using
single-shot readout will be blurrier. More advanced
image reconstruction methods can be used in the fu-
ture to shorten the acquisition period.
It is known that the heart is one of the most difficult
organs for imaging because of constant cardiac motion
and respiratory motion. In CEST CMR scans, in addition
to the motion within the acquisition of one image that
leads to blurriness and the misregistration between differ-
ent images that causes error in pixel-by-pixel mapping, we
are also facing B0 field variations caused by residual mo-
tion. Respiratory phase mismatch, even within the naviga-
tor acceptance window, leads to B0 field variations in the
myocardium for images acquired with different saturation
frequency offsets. Because of the relative position of heart
(tissue) and lung (air) in the lateral wall, the B0 field is
changing rapidly in the heart, especially the lateral wall re-
gion. In this study, 3-pool-model fitting is used to generate
Fig. 4 CEST signal in the scar (0.09 ± 0.02) is significantly reduced
compared to healthy remote myocardium (0.16 ± 0.02), p< 0.001. CEST
signal in the border zone (0.12 ± 0.02) was also reduced compared to
remote myocardium, p< 0.001
Global CEST Signal Septal CEST Signal
ecnereffi
D
ba
Fig. 5 Bland-Altman plots of (a) global CEST signal and (b) septal CEST signal. The dashed lines represent 95% limits of agreement
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CEST signal so the B0 field variations can be treated as
noise. However, this method can address this issue only to
certain extent. Therefore, sometimes inhomogeneity is ob-
served in the CEST map (Fig. 3), especially in the lateral
wall region. This issue can be potentially addressed using
advanced shimming coil design so the B0 field over the
myocardium can be more homogeneous. Another poten-
tial method could be incorporating additional B0 field
information in the data acquisition.
This study shows the feasibility of CEST CMR tech-
nique in healthy subjects and animal studies. Preliminary
patient result is also presented. However, to further
demonstrate the utility of CEST CMR technique in
patients, more comprehensive studies need to be per-
formed. The animal model used in this study only
yielded transmural infarcts. Non-transmural infarcts are
typically smaller in size and may be more difficult to
detect. Whether the spatial resolution and sensitivity
of the current technique is enough for non-transmural in-
farcts requires more studies. Additionally, the data ac-
quired in this study were limited to the left anterior
descending territory. Further studies will be needed to
evaluate the performance of CEST CMR at different arter-
ial territories.
In this study, we applied CEST CMR in the well-
studied chronic infarction model using LGE as reference.
However, CEST CMR should not be seen as a potential
replacement for LGE for scar quantification. As a sup-
plement, CEST CMR provides the unique metabolic in-
formation which could potentially be used to study the
undergoing mechanisms in cardiac dysfunctions. How-
ever, more comprehensive studies still need to be per-
formed to demonstrate the utility of CEST CMR. The
results in this study show that the infarct region has
about 50% drop in CEST signal compared to healthy re-
mote myocardium. In some types of cardiac dysfunc-
tions which have mild metabolic impairment, the
difference of signal could be smaller. Further investiga-
tion is needed to evaluate whether CEST CMR tech-
nique has the reproducibility and sensitivity to detect
cardiac dysfunctions with mild metabolic abnormalities.
Histopathology studies are also needed to demonstrate
the CEST signal change is correlated to creatine distribu-
tion in the myocardium.
Conclusion
We developed a clinically feasible CEST CMR technique
that is significantly faster than the previous approach. In
a chronic myocardial infarction pig model, we demon-
strated the proposed CEST CMR technique can discern
differences in the CEST signal between infarct and
remote myocardium. This study shows the feasibility of
CEST CMR technique in healthy subjects, animal stud-
ies, and a preliminary patient study.
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